Showing results (201-210 of 586) with videos related to
Sort By:
Pageof 59
Journal of the American College of Cardiology|April 3, 2010
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient dataKeith A A Fox, Tim C Clayton, Peter Damman, et al.Heart (British Cardiac Society)|May 6, 2014
Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudyZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.American Heart Journal|July 17, 2019
Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trialAbhinav Sharma, Emil Hagström, Daniel M Wojdyla, et al.Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.American Heart Journal|August 2, 2017
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trialZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.American Heart Journal|September 26, 2006
Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUSPeter R Sinnaeve, Yao Huang, Kris Bogaerts, et al.American Heart Journal|March 3, 2009
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirinChristoph Varenhorst, Stefan James, David Erlinge, et al.Circulation|September 11, 2013
Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy studyEloi Marijon, Jean-Yves Le Heuzey, Stuart Connolly, et al.European Journal of Preventive Cardiology|April 12, 2014
Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factorsOla Vedin, Emil Hagström, Dianne Gallup, et al.Circulation|October 2, 2013
Management and outcomes of major bleeding during treatment with dabigatran or warfarinAmmar Majeed, Hun-Gyu Hwang, Stuart J Connolly, et al.Pageof 59